News: Infinx acquires Glidian to expand AI-driven prior authorization solutions, improving patient access and streamlining ...

addressed challenges with the current accelerated approval pathway, which was created in 1992 to offer patients a way to gain access to novel therapies ahead of final results of a phase 3 trial.

The FDA’s latest draft guidance on accelerated approval for new drugs, “Expedited Program for Serious Conditions—Accelerated ...

Sarepta Therapeutics shares dropped 20% after a patient's death raises Elevidys safety concerns. Read why I am downgrading ...

FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

Trial Library, a leader in AI-enabled clinical trial matching and patient navigation with a strong reputation in oncology, has partnered with American Oncology Network (AON), one of the nation's ...

The Minns Labor Government has awarded funding to a Newcastle-based researcher focussed on improving outcomes for regional and rural cancer patients ...

Trial Library collaborates with American Oncology Network to expand clinical trial access for patients with various cancers: San Francisco Saturday, March 15, 2025, 18:00 Hrs [IST ...

Q4 2024 Earnings Call Transcript March 20, 2025 Abeona Therapeutics Inc. beats earnings expectations. Reported EPS is $-0.24, expectations were $-0.43. Operator: Greetings. Welcome to Abeona ...

China approved 48 first-in-class innovative drugs, as well as a significant number of medications for pediatric and rare ...

This accelerated pathway for new drugs and therapies ... Intelligence and learnings from the delivery of the early and managed patient access schemes will be used to better understand impact ...